|
Name |
Fonsecin
|
Molecular Formula | C15H14O6 | |
IUPAC Name* |
2,5,8-trihydroxy-6-methoxy-2-methyl-3H-benzo[g]chromen-4-one
|
|
SMILES |
CC1(CC(=O)C2=C(C3=C(C=C(C=C3C=C2O1)O)OC)O)O
|
|
InChI |
InChI=1S/C15H14O6/c1-15(19)6-9(17)13-11(21-15)4-7-3-8(16)5-10(20-2)12(7)14(13)18/h3-5,16,18-19H,6H2,1-2H3
|
|
InChIKey |
FKCYENFBFZUSDP-UHFFFAOYSA-N
|
|
Synonyms |
Fonsecin; 3748-39-8; 2,5,8-trihydroxy-6-methoxy-2-methyl-3H-benzo[g]chromen-4-one; MLS000863579; CHEBI:64543; SMR000440773; TMC-256B1; 2,5,8-trihydroxy-6-methoxy-2-methyl-3H-benzo[g][1]benzopyran-4-one; 6-methoxy-2-methyl-2,5,8-tris(oxidanyl)-3H-benzo[g]chromen-4-one; O8-Demethylfonsecin B; 4H-Naphtho(2,3-b)pyran-4-one, 2,3-dihydro-2,5,8-trihydroxy-6-methoxy-2-methyl-; I4J4MWF94J; UNII-I4J4MWF94J; Antibiotic TMC 256B1; cid_216328; MEGxm0_000042; CHEMBL1391235; SCHEMBL21638065; ACon0_001049; ACon1_002280; BDBM67437; TMC 256B1; DTXSID50958567; HMS2269P19; 2,5,8-trihydroxy-6-methoxy-2-methyl-2,3-dihydro-4H-benzo[g]chromen-4-one; NCGC00169993-01; A826144; Q27133340; 2,3-Dihydro-2,5,8-trihydroxy-6-methoxy-2-methyl-4H-naphtho[2,3-b]pyran-4-one, 9CI; 2,5,8-Trihydroxy-6-methoxy-2-methyl-2,3-dihydro-4H-naphtho[2,3-b]pyran-4-onato; 2,5,8-TRIHYDROXY-6-METHOXY-2-METHYL-2H,3H,4H-NAPHTHO[2,3-B]PYRAN-4-ONE; NCGC00169993-02!2,5,8-trihydroxy-6-methoxy-2-methyl-3H-benzo[g]chromen-4-one
|
|
CAS | 3748-39-8 | |
PubChem CID | 216328 | |
ChEMBL ID | CHEMBL1391235 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 290.27 | ALogp: | 2.1 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 96.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.747 |
Caco-2 Permeability: | -4.881 | MDCK Permeability: | 0.00001190 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.083 | 20% Bioavailability (F20%): | 0.023 |
30% Bioavailability (F30%): | 0.148 |
Blood-Brain-Barrier Penetration (BBB): | 0.075 | Plasma Protein Binding (PPB): | 90.74% |
Volume Distribution (VD): | 1.132 | Fu: | 8.32% |
CYP1A2-inhibitor: | 0.913 | CYP1A2-substrate: | 0.89 |
CYP2C19-inhibitor: | 0.055 | CYP2C19-substrate: | 0.162 |
CYP2C9-inhibitor: | 0.222 | CYP2C9-substrate: | 0.835 |
CYP2D6-inhibitor: | 0.359 | CYP2D6-substrate: | 0.332 |
CYP3A4-inhibitor: | 0.408 | CYP3A4-substrate: | 0.16 |
Clearance (CL): | 14.633 | Half-life (T1/2): | 0.788 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.05 |
Drug-inuced Liver Injury (DILI): | 0.832 | AMES Toxicity: | 0.121 |
Rat Oral Acute Toxicity: | 0.057 | Maximum Recommended Daily Dose: | 0.349 |
Skin Sensitization: | 0.498 | Carcinogencity: | 0.045 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.162 |
Respiratory Toxicity: | 0.376 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000938 | 0.773 | D07MGA | 0.405 | ||||
ENC005777 | 0.577 | D06GCK | 0.313 | ||||
ENC005281 | 0.494 | D0K8KX | 0.286 | ||||
ENC006014 | 0.485 | D04AIT | 0.278 | ||||
ENC002884 | 0.433 | D0AZ8C | 0.260 | ||||
ENC005172 | 0.433 | D0C1SF | 0.258 | ||||
ENC003031 | 0.426 | D0J4IX | 0.253 | ||||
ENC000969 | 0.426 | D01XWG | 0.250 | ||||
ENC000984 | 0.423 | D07EXH | 0.246 | ||||
ENC004794 | 0.418 | D0C9XJ | 0.244 |